Get startedLog in
    Picture of Median Technologies SA logo

    ALMDT — Median Technologies SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Median Technologies SA - Aims To Obtain Full Device Approval & Market Authorization By 2023 End For Ibiopsy® Lung Cancer Screening Cade/Cadx Software

    Picture of Median Technologies SA logoMedian Technologies SA
    03/03/2022 16:47
    * MEDIAN TECHNOLOGIES SA - AIMS TO OBTAIN FULL DEVICE
APPROVAL &
MARKET AUTHORIZATION BY 2023 END FOR IBIOPSY® LUNG CANCER
SCREENING CADE/CADX SOFTWARE
    * MEDIAN TECHNOLOGIES SA - FDA IS EXPECTED TO REVIEW 513(G)
SUBMISSION AND PROVIDE FEEDBACK WITHIN 60 CALENDAR DAYS

Source text for Eikon:  ID:nBw19fPpQa 
Further company coverage: [ ]

    Recent news on Median Technologies SA

    See all news